drugset / Trial / NCT07244289

Managed Access Programs for VAY736, Ianalumab

NCT07244289

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to VAY736, ianalumab

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Ianalumab Monoclonal antibody